| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 11.947 | 84.581 | 95.425 | 97.036 | 103.320 |
| Total Income - EUR | - | - | - | - | 0 | 11.947 | 87.994 | 99.550 | 97.055 | 103.418 |
| Total Expenses - EUR | - | - | - | - | 63 | 4.480 | 40.380 | 49.740 | 64.513 | 76.878 |
| Gross Profit/Loss - EUR | - | - | - | - | -63 | 7.468 | 47.615 | 49.809 | 32.542 | 26.540 |
| Net Profit/Loss - EUR | - | - | - | - | -63 | 7.348 | 46.768 | 48.855 | 31.572 | 23.438 |
| Employees | - | - | - | - | 0 | 1 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Neuromed Dorna S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 88 | 786 | 19.672 | 23.343 | 32.502 | 81.806 |
| Current Assets | - | - | - | - | 102 | 11.969 | 51.545 | 20.741 | 17.847 | 12.605 |
| Inventories | - | - | - | - | 0 | 4 | 1.612 | 297 | 301 | 113 |
| Receivables | - | - | - | - | 0 | 7.728 | 37.932 | 1.095 | 9.688 | 22 |
| Cash | - | - | - | - | 102 | 4.237 | 12.000 | 19.349 | 7.858 | 12.469 |
| Shareholders Funds | - | - | - | - | -21 | 7.328 | 53.934 | 37.811 | 45.097 | 46.431 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 211 | 5.427 | 17.282 | 6.273 | 5.252 | 47.980 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuromed Dorna S.r.l.